Clinical decisions. Management of type 2 diabetes

N Engl J Med. 2008 Jan 17;358(3):293-7. doi: 10.1056/NEJMclde0708469.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Glipizide / therapeutic use
  • Glucagon-Like Peptide 1 / agonists
  • Humans
  • Hypertension / complications
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / therapeutic use
  • Metformin / therapeutic use
  • Middle Aged
  • Obesity / complications
  • Pioglitazone
  • Thiazolidinediones / therapeutic use

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Insulin
  • Thiazolidinediones
  • Glucagon-Like Peptide 1
  • Metformin
  • Pioglitazone
  • Glipizide